Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes

FEBS Letters

Volumn 582, Issue 5, 2008, Pages 579-585

  Koga, Tomohiro ^a   Torigoshi, Takafumi ^a   Motokawa, Satoru ^a   Miyashita, Taichiro ^a   Maeda, Yumi ^a   Nakamura, Minoru ^a   Komori, Atsumasa ^a   Aiba, Yoshihiro ^a   Uemura, Takashi ^a   Yatsuhashi, Hiroshi ^a   Ishibashi, Hiromi ^a   Eguchi, Katsumi ^b   Migita, Kiyoshi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 6; Nuclear factor kappa B; Rheumatoid arthritis; Serum amyloid A protein

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; SERUM AMYLOID A; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBROBLAST; GENE EXPRESSION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; DNA; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SYNOVIAL FLUID; TRANSCRIPTION FACTOR RELA;

EID: 39649101078     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.01.022     Document Type: Article

References (31)

1. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265 (1999) 501-523
2. Jensen L.E., and Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334 (1998) 489-503
3. Upragarin N., Landman W.J., Gaastra W., and Gruys E. Extrahepatic production of acute phase serum amyloid A. Histol. Histopathol. 20 (2005) 1295-1307
4. Patel H., Fellowes R., Coade S., and Woo P. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48 (1998) 410-418
5. Lee M.S., Yoo S.A., Cho C.S., Suh P.G., Kim W.U., and Ryu S.H. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J. Immunol. 177 (2006) 5585-5594
6. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel DF., Bausserman L.L., Kelvin D.J., and Oppenheim J.J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180 (1994) 203-209
7. He R., Sang H., and Ye R.D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101 (2003) 1572-1581
8. Furlaneto C.J., and Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268 (2000) 405-408
9. Hatanaka E., Furlaneto C.J., Ribeiro F.P., Souza G.M., and Campa A. Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol. Lett. 91 (2004) 33-37
10. Muller-Ladner U., Pap T., Gay R.E., Neidhart M., and Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 1 (2005) 102-110
11. Martel-Pelletier J., Welsch D.J., and Pelletier J.P. Metalloproteases and inhibitors in arthritic diseases. Best Pract. Res. Clin. Rheumatol. 15 (2001) 805-829
12. Sweeney S.E., and Firestein G.S. Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 36 (2004) 372-378
13. Kumon Y., Loose L.D., Birbara C.A., and Sipe J.D. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein. J. Rheumatol. 24 (1997) 14-19
14. Kumon Y., Suehiro T., Hashimoto K., Nakatani K., and Sipe J.D. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J. Rheumatol. 26 (1999) 785-790
15. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., and Bresnihan B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 50 (2004) 1788-1799
16. Migita K., Kawabe Y., Tominaga M., Origuchi T., Aoyagi T., and Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab. Invest. 78 (1998) 535-539
17. Vallon R., Freuler F., Desta-Tsedu N., Robeva A., Dawson J., Wenner P., Engelhardt P., Boes L., Schnyder J., Tschopp C., Urfer R., and Baumann G. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166 (2001) 2801-2807
18. Sukenik S., Henkin J., Zimlichman S., Skibin A., Neuman L., Pras M., Horowitz J., and Shainkin-Kestenbaum R. Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis. J. Rheumatol. 15 (1998) 942-945
19. Ahn K.S., and Aggarwal B.B. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann. NY Acad. Sci. 1056 (2005) 218-233
20. Nishimoto N. Interleukin-6 in rheumatoid arthritis. Curr. Opin. Rheumatol. 18 (2006) 277-281
21. Houssiau F.A., Devogelaer J.P., Van Damme J., de Deuxchaisnes C.N., and Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31 (1988) 784-788
22. Nishimoto N., and Kishimoto T. Interleukin 6: from bench to bedside. Nat. Clin. Pract. Rheumatol. 2 (2006) 619-626
23. Baumann H., and Kushner I. Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis. Am. J. Pathol. 152 (1998) 641-644
24. Guerne P.A., Zuraw B.L., Vaughan J.H., Carson D.A., and Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J. Clin. Invest. 83 (1989) 585-592
25. Schultz D.R., and Arnold P.I. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin. Arthritis Rheum. 20 (1990) 129-147
26. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996) 397-440
27. Ray A., Schatten H., and Ray B.K. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J. Biol. Chem. 274 (1999) 4300-4308
28. Muller-Ladner U., Gay R.E., and Gay S. Role of nuclear factor kappaB in synovial inflammation. Curr. Rheumatol. Rep. 4 (2002) 201-207
29. Schulze-Osthoff K., Ferrari D., Riehemann K., and Wesselborg S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 198 (1997) 35-49
30. Georganas C., Liu H., Perlman H., Hoffmann A., Thimmapaya B., and Pope R.M. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J. Immunol. 165 (2000) 7199-7206
31. Neff L., Zeisel M., Sibilia J., Scholler-Guinard M., Klein J.P., and Wachsmann D. NF-kappaB and the MAP kinases/AP-1 pathways are both involved in interleukin-6 and interleukin-8 expression in fibroblast-like synoviocytes stimulated by protein I/II, a modulin from oral streptococci. Cell Microbiol. 3 (2001) 703-712